SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it will present at several high-profile events in March, including the 27th Annual ROTH Conference and the 5th Annual “Cancer Immunotherapy: A Long- Awaited Reality” Conference.
Help employers find you! Check out all the jobs and post your resume.
